Innovation in Pharma & MedTech


Scheme for Promotion of Research and Innovation in Pharma MedTech Sector (PRIP)

Objectives of the Scheme :-

  • Transform Indian Pharma MedTech sector.
  • Move from cost based to innovation-based growth.
  • Strengthen the research infrastructure in the country.
  • Promote industry-academia linkage for R&D in priority areas.
  • Inculcate the culture of quality research and nurture our pool of scientists.

Scheme Categories

Category A aims to setup more National Institutes for Pharma Education & Research (NIPERs)

Category B aims to offer incentives to corporates for undertaking research. Category B has three subparts as under:-

  • Selection of 9 established Pharma companies who are willing to carry out research in six priority areas with academic collaboration in Govt. institute of national repute to offer 35% Capex Subsidy for Research (capped at ₹ 125 Crores)


  • Funding would be provided to Thirty research projects in six priority areas which are at successfully validated level (TRL 5) to reach TRL 9 @ 35% of the cost or ₹ 100 Cr whichever is less over a period of 5 years on the principle of benefit sharing.


  • Funding would be provided to 125 research projects in six priority areas to help Indian startups and MSMEs to reach TRL 4.


Overall Financial Outlay – ₹ 5,000 Crores

Scheme Validity – 5 Years

To know more about the scheme, read our publication (Scheme_for_PRIP) or contact us



More Posts

Digital Advertisement Policy

Digital Advertisement Policy

It is a significant move to harness the potential of digital media for government communication. This policy empowers the Central Bureau of Communication (CBC), the

Send Us A Message